Page last updated: 2024-09-03

vadimezan and Blood Clot

vadimezan has been researched along with Blood Clot in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L; Cheng, G; Ding, Z; Gu, J; Kunapuli, SP; Mruk, JS; Shen, J; Zhang, S; Zhang, SH; Zhang, Y; Zhu, L1
Baguley, BC; Gavin, JB; Wilson, WR; Zwi, LJ1

Other Studies

2 other study(ies) available for vadimezan and Blood Clot

ArticleYear
Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid inhibits platelet activation and thrombosis via inhibition of thromboxane A2 signaling and phosphodiesterase.
    Journal of thrombosis and haemostasis : JTH, 2013, Volume: 11, Issue:10

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Animals; Antineoplastic Agents; Humans; MAP Kinase Signaling System; Mice; Phosphodiesterase Inhibitors; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Thrombosis; Thromboxane A2; Thromboxane-A Synthase; Xanthones

2013
Necrosis in non-tumour tissues caused by flavone acetic acid and 5,6-dimethyl xanthenone acetic acid.
    British journal of cancer, 1990, Volume: 62, Issue:6

    Topics: Animals; Antineoplastic Agents; Endometrium; Female; Flavonoids; Lymphoid Tissue; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Necrosis; Thrombosis; Xanthenes; Xanthones

1990